These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


131 related items for PubMed ID: 21922418

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery.
    Chen Q, Gong T, Liu J, Wang X, Fu H, Zhang Z.
    J Drug Target; 2009 May; 17(4):318-28. PubMed ID: 19558357
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Circadian rhythms of TRH-like peptide levels in rat brain.
    Pekary AE, Stevens SA, Sattin A.
    Brain Res; 2006 Dec 13; 1125(1):67-76. PubMed ID: 17113044
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood-Brain Barrier and into Human and Mouse Brain Parenchymal Cells.
    Montaser AB, Järvinen J, Löffler S, Huttunen J, Auriola S, Lehtonen M, Jalkanen A, Huttunen KM.
    ACS Chem Neurosci; 2020 Dec 16; 11(24):4301-4315. PubMed ID: 33228353
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neuropeptides and the blood-brain barrier.
    Pardridge WM, Frank HJ, Cornford EM, Braun LD, Crane PD, Oldendorf WH.
    Adv Biochem Psychopharmacol; 1981 Dec 16; 28():321-8. PubMed ID: 7010940
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model.
    Chen W, Yang JZ, Andersen R, Nielsen LH, Borchardt RT.
    J Pharmacol Exp Ther; 2002 Nov 16; 303(2):849-57. PubMed ID: 12388672
    [Abstract] [Full Text] [Related]

  • 37. A pyridinium-substituted analog of the TRH-like tripeptide pGlu-Glu-Pro-NH2 and its prodrugs as central nervous system agents.
    Prokai-Tatrai K, Teixido M, Nguyen V, Zharikova AD, Prokai L.
    Med Chem; 2005 Mar 16; 1(2):141-52. PubMed ID: 16787309
    [Abstract] [Full Text] [Related]

  • 38. Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.
    Lalatsa A, Schätzlein AG, Garrett NL, Moger J, Briggs M, Godfrey L, Iannitelli A, Freeman J, Uchegbu IF.
    J Control Release; 2015 Jan 10; 197():87-96. PubMed ID: 25449808
    [Abstract] [Full Text] [Related]

  • 39. L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.
    Puris E, Gynther M, Huttunen J, Petsalo A, Huttunen KM.
    J Control Release; 2017 Sep 10; 261():93-104. PubMed ID: 28662899
    [Abstract] [Full Text] [Related]

  • 40. Prodrugs--from serendipity to rational design.
    Huttunen KM, Raunio H, Rautio J.
    Pharmacol Rev; 2011 Sep 10; 63(3):750-71. PubMed ID: 21737530
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.